세계의 CZT 검출기 시장(-2035년) : 유형별, 최종사용자별, 에너지 범위별, 지역별

The CZT detector market is expected to attain a valuation of USD 481.3 million, registering a robust 13.4% CAGR through the end of 2035. The CZT detector is a semiconductor device made from cadmium, zinc, and tellurium, designed to detect X-ray and gamma radiation with exceptional precision. Its ability to operate at room temperature and provide fast, accurate energy readings makes it valuable in healthcare and nuclear applications.

One of the main reasons for the growth of the CZT detector market is the need for high-end diagnostic imaging and precision medicine. These detectors provide a better energy resolution, can be used at room temperature, and result in lower radiation doses, which is why they are the weapons of choice in SPECT, PET, and hybrid imaging systems for the correct diagnosis of cancer, cardiac, and neurological diseases throughout the advanced healthcare ecosystems.

Major Company Development

Mirion Technologies made 2025 very significant with major moves, such as unveiling the Vital Platform for digital integration, partnering with Westinghouse to drive nuclear innovation, launching the groundbreaking CSPEvo(R) radiation detection family, enhancing the quality of radiopharmaceuticals via Apex-Guard software, and getting TerraPower Natrium(R) Reactor demonstration contracts, solidifying its leadership in the nuclear technology sector.

Key Players

Major players in the global CZT detector market include Kromek Group plc, Mirion Technologies, GE Healthcare, Redlen Technologies, Imdetek Corporation, XZ LAB, ZRF Ritec SIA, Baltic Scientific Instruments (BSI), Gammadata Group, and Radiation Detection Technologies, Inc.

Key Report Attributes

• Market Size 2024: USD 127.6 Million
• Market Size 2035: USD 481.3 Million
• CAGR (2025-2035): 13.4%
• Base Year: 2024
• Market Forecast Period: 2025-2035

Industry Segmentations Growth

• By Type: Handheld CZT Detectors/ Portable - 13.9%, Vehicle-Mounted CZT Detectors - 12.4%.
• By End Use: Security and Defense - 14.3%, Industrial - 13.5%.
• By Energy Range: Low Energy - 13.7%, Medium Energy - 13.3%.

Regional Analysis

North America still holds the major market for CZT detectors, which is attributable to the region's state-of-the-art healthcare systems and generous R&D funding. The U.S. is going through a wide-scale incorporation of CZT-powered nuclear imaging methods for cancer and cardiac care, combined with defense-driven initiatives to monitor radiation. With a combined valuation of USD 46.7 million in 2024, North America continues to dominate the CZT detector market, propelled by high-end medical imaging demand in the U.S. and Canada's growing diagnostic infrastructure.

Across Europe, the market expansion is influenced by the growth of the healthcare facilities and a solid presence of the research institutes in the field of nuclear imaging. Germany and the UK are forefront in the implementation of CZT-based PET and SPECT systems to facilitate precision medicine projects. Europe's CZT detector market stood at USD 19.5 million in 2024, reflecting robust utilization across Germany, the UK, and France as hospitals shift toward advanced nuclear imaging systems.

The Asia Pacific region is becoming a very dynamic player due to health care reforms that are government-supported and an initiative for the local production of cheap CZT systems. China, India, and Japan are progressing with early disease detection through the use of advanced imaging platforms, and countries like South Korea and Australia are directing their investments towards nuclear security infrastructure. The Asia-Pacific market, worth USD 23.6 million in 2024, shows strong momentum led by China and Japan, where rising investments in healthcare innovation and radiation monitoring are fueling growth.

South America's CZT detector market is progressing at a measured pace, centered around healthcare upgrades in Brazil and Argentina. Increased focus on early cancer detection and compliance with global diagnostic standards is encouraging the adoption of CZT imaging systems. Additionally, stricter radiation safety norms in mining and industrial sectors are creating fresh opportunities for portable detection devices.

The MEA market for CZT detectors is gradually maturing, supported by modernization of healthcare and nuclear security initiatives. GCC nations, led by Saudi Arabia and the UAE, are integrating high-end CZT imaging systems into new diagnostic facilities. In Africa, progress is uneven but steady, with South Africa emerging as a regional hub for nuclear medicine and industrial radiation management.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 MARKET OVERVIEW:
• 1.2 MARKET SEGMENTATION
• 1.3 FUTURE OUTLOOK

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET END USER ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.6.2 DATA FORECASTING
  • 3.6.3 DATA FORECASTING TECHNIQUE
• 3.7 DATA MODELING
  • 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.7.2 DATA MODELING:

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 GROWING DEMAND FOR ADVANCED MEDICAL IMAGING
  • 4.2.2 INCREASE IN NUCLEAR FACILITY DEVELOPMENTS
  • 4.2.3 RISING DEMAND FOR SECURITY AND SAFETY APPLICATIONS
  • 4.2.4 TECHNOLOGICAL ADVANCEMENTS IN DETECTOR MATERIALS
  • 4.2.5 GOVERNMENT INVESTMENTS IN RESEARCH AND DEVELOPMENT
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COST OF CZT DETECTORS
  • 4.3.2 LIMITED AVAILABILITY OF RAW MATERIALS
  • 4.3.3 STRINGENT REGULATORY POLICIES
  • 4.3.4 TECHNOLOGICAL COMPLEXITY IN MANUFACTURING
  • 4.3.5 COMPETITION FROM ALTERNATIVE DETECTION TECHNOLOGIES
• 4.4 OPPORTUNITY
  • 4.4.1 EXPANSION IN EMERGING MARKETS
  • 4.4.2 ADVANCEMENTS IN MINIATURIZATION TECHNIQUES
• 4.5 IMPACT ANALYSIS OF COVID - 19

5 MARKET FACTOR ANALYSIS

• 5.1 SUPPLY CHAIN ANALYSIS
  • 5.1.1 RAW MATERIAL SOURCING
  • 5.1.2 CRYSTAL SYNTHESIS AND INGOT PRODUCTION
  • 5.1.3 DETECTOR FABRICATION AND PROCESSING
  • 5.1.4 COMPONENT INTEGRATION AND ASSEMBLY
  • 5.1.5 DISTRIBUTION AND LOGISTICS
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS (LOW)
  • 5.2.2 BARGAINING POWER OF SUPPLIERS (HIGH)
  • 5.2.3 THREAT OF SUBSTITUTES (MODERATE)
  • 5.2.4 BARGAINING POWER OF BUYERS (MODERATE)
  • 5.2.5 INTENSITY OF RIVALRY (MODERATE)

6 GLOBAL CZT DETECTOR MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 HANDHELD CZT DETECTOR
• 6.3 VEHICLE-MOUNTED CZT DETECTOR
• 6.4 PORTABLE CZT DETECTOR
• 6.5 FIXED CZT DETECTOR

7 GLOBAL CZT DETECTOR MARKET, BY END-USE

• 7.1 INTRODUCTION
• 7.2 SECURITY AND DEFENSE
• 7.3 INDUSTRIAL
• 7.4 MEDICAL
• 7.5 CUSTOMS AND BORDER PROTECTION

8 GLOBAL CZT DETECTOR MARKET, BY ENERGY RANGE

• 8.1 INTRODUCTION
• 8.2 LOW ENERGY (LESS THAN 100KEV)
• 8.3 MEDIUM ENERGY (100-300KEV)
• 8.4 HIGH ENERGY (MORE THAN 300KEV)

9 GLOBAL CZT DETECTOR MARKET, BY REGION

• 9.1 GLOBAL
• 9.2 NORTH AMERICA
  • 9.2.1 USA
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 UNITED KINGDOM
  • 9.3.2 GERMANY
  • 9.3.3 FRANCE
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 RUSSIA
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 SOUTH KOREA
  • 9.4.3 INDIA
  • 9.4.4 JAPAN
  • 9.4.5 INDONESIA
  • 9.4.6 MALAYSIA
  • 9.4.7 THAILAND
  • 9.4.8 REST OF ASIA PACIFIC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
  • 9.5.2 MEXICO
  • 9.5.3 ARGENTINA
  • 9.5.4 REST OF SOUTH AMERICA
• 9.6 MIDDEL EAST AND AFRICA
  • 9.6.1 GCC COUNTRIES
  • 9.6.2 SOUTH AFRICA
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS, 2024
• 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

• 11.1 KROMEK GROUP PLC
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 PRODUCTS OFFERED
  • 11.1.3 KEY DEVELOPMENTS
  • 11.1.4 SWOT ANALYSIS
  • 11.1.5 FINANCIAL ANALYSIS
  • 11.1.6 KEY STRATEGY
• 11.2 MIRION TECHNOLOGIES, INC.
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 PRODUCTS OFFERED
  • 11.2.3 KEY DEVELOPMENTS
  • 11.2.4 SWOT ANALYSIS
  • 11.2.5 FINANCIAL ANALYSIS
  • 11.2.6 KEY STRATEGY
• 11.3 GE HEALTHCARE TECHNOLOGIES, INC.
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 PRODUCTS OFFERED
  • 11.3.3 KEY DEVELOPMENTS
  • 11.3.4 SWOT ANALYSIS
  • 11.3.5 FINANCIAL ANALYSIS
  • 11.3.6 KEY STRATEGY
• 11.4 REDLEN TECHNOLOGIES
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 PRODUCTS OFFERED
  • 11.4.3 KEY DEVELOPMENTS
  • 11.4.4 SWOT ANALYSIS
  • 11.4.5 KEY STRATEGY
• 11.5 IMDETEK CORPORATION (SHAANXI IMDETEK CO., LTD.)
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 PRODUCTS OFFERED
  • 11.5.3 SWOT ANALYSIS
  • 11.5.4 KEY STRATEGY
• 11.6 XZ LAB
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 PRODUCTS OFFERED
  • 11.6.3 SWOT ANALYSIS
  • 11.6.4 KEY STRATEGY
• 11.7 ZRF RITEC SIA
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 PRODUCTS OFFERED
  • 11.7.3 SWOT ANALYSIS
  • 11.7.4 KEY STRATEGY
• 11.8 BALTIC SCIENTIFIC INSTRUMENTS (BSI)
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 PRODUCTS OFFERED
  • 11.8.3 SWOT ANALYSIS
  • 11.8.4 KEY STRATEGY
• 11.9 RADIATION DETECTION TECHNOLOGIES, INC.
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 PRODUCTS OFFERED
  • 11.9.3 SWOT ANALYSIS
  • 11.9.4 KEY STRATEGY
• 11.10 GAMMADATA INSTRUMENTS AB
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 PRODUCTS OFFERED
  • 11.10.3 SWOT ANALYSIS
  • 11.10.4 KEY STRATEGY